The Yates group showed that TNF-R1, CD95, and DR5 are located in caveolin-1 positive DRM fractions of U-1242 glioma cells by default and that TRAIL treatment invoked caspase-8 recruitment and activation in this compartment [49,50]. Here, TNFRSF10B is linked to glioma.